Biotech Values

[DewDiligence]

Tidbit from AGN/Oculex CC:

In last week’s conference call to announce Allergan’s acquisition of Oculex, Allergan’s CEO, Davis Pyott, said this (about 13 minutes into the call):

“Our real challenge is sorting through all these different opportunities and seeing which ones we can fund… and of course we continue to look to external things and, frankly, if we find something that’s better than what we’ve got, we will basically throw one of the babies out of the boat and take the new one in…”

http://www.shareholder.com/agn/medialist.cfm?id=&largeText= [second link down]

Hmm...